Nucleosys Tech Competitors

The agency where curiosity builds change. We are in the business of real change—the kind that drives earlier diagnoses, accelerates adoption of breakthrough therapies, and ultimately delivers better health and better outcomes. Real change happens when beliefs shift. When science, story, and strategy converge in exactly the right way—in the head and the heart. We fuse evidence and emotion—never choosing between them—to develop captivating, belief-shifting experiences that move markets and move hearts. We are more than an HCP or patient agency. Our full-service, omnichannel capabilities span high-stakes, therapeutic categories, powered by a team of curious minds, brave hearts, and ready hands. We push one another to uncover truths, discover potential, and create energy that moves the needle forward. If you're ready to cultivate curiosity, speak with courage, and make a real difference in healthcare, explore our open positions. We're looking for people who want to build change alongside us.

Medigene AG (FSE: MDG1) is a leading immuno-oncology platform company dedicated to developing T-cell therapies to effectively eliminate cancer. Its end-to-end technology platform is built on multiple proprietary exclusive product development and product enhancement technologies, and allows Medigene to create best-in-class differentiated, T cell receptor engineered T cell (TCR-T) therapies for multiple solid tumor indications that are optimized for both safety and efficacy. This platform provides product candidates for both its in-house therapeutics pipeline and partnering. For more information, please visit www.medigene.com

At Nanogen, Inc., we develop diagnostic products that enable physicians to deliver improved patient care. Our products allow faster and easier diagnosis, treatment and monitoring of cardiovascular disease and infectious diseases. These products include molecular diagnostic kits and reagents, and rapid test kits, which can be used in urgent care settings or at the point-of-care.